Widgerow Alan D, Ziegler Mary E, Casas Laurie A
Alastin Skincare, Carlsbad, CA, USA.
Center for Tissue Engineering, University of California Irvine, Irvine, CA, USA.
Aesthet Surg J Open Forum. 2021 Aug 7;3(3):ojab029. doi: 10.1093/asjof/ojab029. eCollection 2021 Sep.
TriHex Technology (Alastin Skincare, Carlsbad, CA) has been shown clinically to promote healing and outcomes post procedures and has been demonstrated clinically to improve lipid droplet dissolution and patient-reported outcomes post procedure. Histologically, the formulations have proven to regenerate collagen and elastin. The use of the technology to prepare the skin for surgical procedures combined with its use post procedure was assessed through clinical study outcomes, histological evidence, and gene expression analyses and demonstrated remodeling of the extracellular matrix (ECM), accelerating healing, and initiation of anti-inflammatory genes. While the improvement in clinical signs and outcomes has been validated, the changes taking place at a molecular level need to be explored. The interaction of cells (adipocytes, macrophages, fibroblasts) and the ECM proteins (collagen, elastin) secondary to the effects of the topical agent application are discussed. It appears that the manipulation of fat during body contouring surgery and the resultant adipocytolysis precipitates a molecular profile that can be positively directed toward hastened healing by using adjuvant topical applications as preconditioning prior to surgery and after the surgical procedure. Here, we review the literature and underlying physiology relating to these products and describe how interleukin 6 appears to be the primary facilitator of these effects.
TriHex技术(Alastin Skincare公司,加利福尼亚州卡尔斯巴德)经临床证明可促进术后愈合及改善预后,还能提高脂质小滴溶解能力并改善患者术后报告的结果。从组织学角度来看,该配方已被证明能使胶原蛋白和弹性蛋白再生。通过临床研究结果、组织学证据和基因表达分析,评估了该技术在手术前用于皮肤准备以及术后使用的情况,结果表明其可重塑细胞外基质(ECM)、加速愈合并启动抗炎基因。虽然临床体征和结果的改善已得到验证,但分子水平上发生的变化仍有待探索。本文讨论了局部用药后细胞(脂肪细胞、巨噬细胞、成纤维细胞)与ECM蛋白(胶原蛋白、弹性蛋白)之间的相互作用。在身体塑形手术中对脂肪的操作及由此产生的脂肪分解似乎会引发一种分子特征,通过在手术前和手术后使用辅助性局部用药作为预处理,可以积极引导这种分子特征朝着加速愈合的方向发展。在此,我们回顾了与这些产品相关的文献和基础生理学知识,并描述了白细胞介素6似乎是这些作用的主要促进因子。